HuagongsheHuagongshe Chemistry Print Report · For research reference only
Ethyl 2-chloro-4-(trifluoromethyl)pyrimidine-5-carboxylate → 2-[(R)-4-(6-Chloro-4,5-dimethyl-pyridazin-3-yl)-2-methyl-piperazin-1-yl]-4-trifluoromethyl-pyrimidine-5-carboxylic acid ethyl ester
Participants
| Role | Name | HCID | Charge |
|---|---|---|---|
| Reactant | Ethyl 2-chloro-4-(trifluoromethyl)pyrimidine-5-carboxylate | HCID 2780355 | — |
| Reactant | 3-chloro-4,5-dimethyl-6-((R)-3-methyl-piperazin-1-yl)-pyridazine | HCID 59191518 | — |
| Product | 2-[(R)-4-(6-Chloro-4,5-dimethyl-pyridazin-3-yl)-2-methyl-piperazin-1-yl]-4-trifluoromethyl-pyrimidine-5-carboxylic acid ethyl ester | HCID 59191458 | 97.2% |
Reaction Steps
Following the protocol above with 2-chloro-4-trifluoromethyl-pyrimidine-5-carboxylic acid ethyl ester (400 mg, 1.57 mmol, 1 eq) and 3-chloro-4,5-dimethyl-6-((R)-3-methyl-piperazin-1-yl)-pyridazine (400 mg, 1.66 mmol, 1 eq) affords 700 mg of desired product as a white solid (97%).
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| Patent number | US09409871B2 |
| Source dataset | uspto-grants-2016_08 |
| ORD ID | ord-3308ada6e9b24e7fa1ab3662d359a8f2 |
| Source note | uspto-grants-2016_08 |